Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Genzyme Completes Drug Rights Deal with Bayer

By Pharmaceutical Processing | June 2, 2009

CAMBRIDGE, Mass. (AP) — Genzyme Corp. said Tuesday it closed the licensing deal for commercialization rights to Bayer’s cancer drug Campath. The licensing agreement, announced in March, was part of a deal potentially worth $1.25 billion for Bayer and included two other treatments. The deal means that Genzyme will have primary responsibility for the development and sales of Campath as a multiple sclerosis drug, for which it its being studied. Bayer will continue to fund a portion of the drug’s development and retains co-promotion rights. If approved as a multiple sclerosis drug, Bayer will receive payments of up to $1.25 billion contingent on annual revenue from the drugs. The deal also included rights to the cancer drugs Fludara and Leukine. Under the deal, Genzyme will make no upfront payment but will make payments to Bayer following approval of Campath as a multiple sclerosis drug, based on product revenue. It will also make future payments based on revenue of Fludara and Leukine.

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards